Compound Detail
CHEMBL270515
DELANZOMIB 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
CC(C)C[C@H](NC(=O)[C@@H](NC(=O)c1cccc(-c2ccccc2)n1)[C@@H](C)O)B(O)O
Basic Information
| ChEMBL ID | CHEMBL270515 |
| Name | DELANZOMIB |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | SJFBTAPEPRWNKH-CCKFTAQKSA-N |
13
Targets
24
Activities
2
Assay Types
18
PK Parameters
20
Publications
10
Known Names
1
Indications
Molecular Properties
413.3
MW (Da)
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Indications
Multiple Myeloma
Activity Summary
IC50 22 meas. best 9.0
EC50 2 meas. best 7.87
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Proteasome subunit beta type-9 CHEMBL1944495 | IC50 | 9.0 | 9.0 | 1.0 | 1 |
| Proteasome Macropain subunit MB1 CHEMBL4662 | IC50 | 8.82 | 8.6 | 1.5 | 3 |
| Proteasome subunit beta type-8 CHEMBL5620 | IC50 | 8.52 | 8.52 | 3.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 8.42 | 6.9833 | 3.8 | 6 |
| Proteasome subunit beta type-10 CHEMBL3317334 | IC50 | 8.0 | 8.0 | 10.0 | 1 |
| Cathepsin G CHEMBL4071 | EC50 | 7.87 | 7.87 | 13.5 | 1 |
| Unchecked CHEMBL612545 | EC50 | 7.87 | 7.87 | 13.5 | 1 |
| Cathepsin G CHEMBL4071 | IC50 | 7.86 | 6.77 | 13.7 | 2 |
| A2780 CHEMBL614004 | IC50 | 7.86 | 7.86 | 13.7 | 1 |
| Proteasome component C5 CHEMBL4208 | IC50 | 7.51 | 7.51 | 31.0 | 1 |
| SARS-CoV-2 CHEMBL4303835 | IC50 | 5.89 | 5.89 | 1300.0 | 2 |
| Cytochrome P450 3A4 CHEMBL340 | IC50 | 5.46 | 5.46 | 3500.0 | 1 |
| Proteasome Macropain subunit CHEMBL3492 | IC50 | 5.46 | 5.46 | 3500.0 | 1 |
| Neutrophil elastase CHEMBL248 | IC50 | 5.45 | 5.45 | 3550.0 | 1 |
| Chymase CHEMBL4068 | IC50 | 5.45 | 5.45 | 3530.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 1030.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 2910.0 | ng.hr.mL-1 | Mus musculus |
| AUC | 2200.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 2850.0 | ng.hr.mL-1 | Mus musculus |
| CL | 3.167 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 23.33 | mL.min-1.kg-1 | Mus musculus |
| F | 54.0 | % | Rattus norvegicus |
| F | 39.0 | % | Mus musculus |
| F | 54.0 | % | Rattus norvegicus |
| F | 39.0 | % | Mus musculus |
| T1/2 | 71.0 | hr | Rattus norvegicus |
| T1/2 | 86.0 | hr | Rattus norvegicus |
| T1/2 | 15.0 | hr | Mus musculus |
| T1/2 | 53.0 | hr | Mus musculus |
| T1/2 | 0.6667 | hr | Mus musculus |
| T1/2 | 0.25 | hr | Rattus norvegicus |
| T1/2 | 0.6667 | hr | Canis lupus familiaris |
| T1/2 | 0.6667 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 18247547 | 10.1021/jm7010589 | Unchecked | 9 |
| 18247547 | 10.1021/jm7010589 | Mus musculus | 8 |
| 18247547 | 10.1021/jm7010589 | Rattus norvegicus | 7 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 4 |
| 18247547 | 10.1021/jm7010589 | Plasma | 4 |
| 18247547 | 10.1021/jm7010589 | Neutrophil elastase | 2 |
| 18247547 | 10.1021/jm7010589 | Chymase | 2 |
| 18247547 | 10.1021/jm7010589 | Liver | 2 |
| - | 10.6019/CHEMBL4495565 | ADMET | 2 |
| 18247547 | 10.1021/jm7010589 | Liver microsomes | 2 |
| 28642029 | 10.1016/j.bmc.2017.06.011 | Unchecked | 2 |
| 18247547 | 10.1021/jm7010589 | Cathepsin G | 2 |
| - | 10.6019/CHEMBL4495565 | Vero C1008 | 2 |
| 20925433 | 10.1021/jm100189a | Cathepsin G | 2 |
| 18247547 | 10.1021/jm7010589 | Cathepsin D | 1 |
| 18247547 | 10.1021/jm7010589 | Dipeptidyl peptidase 1 | 1 |
| 18247547 | 10.1021/jm7010589 | Cathepsin B | 1 |
| - | 10.6019/EOS300108 | HepG2 | 1 |
| 18247547 | 10.1021/jm7010589 | Cytochrome P450 1A2 | 1 |
| 18247547 | 10.1021/jm7010589 | Cytochrome P450 2C19 | 1 |
Data from ChEMBL 36 via Core Engine